Neuroleptic medications inhibit complex I of the electron transport chain
โ Scribed by Vernice Jackson-Lewis; Serge Przedborski
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 246 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
โฆ Synopsis
Kano and associates [I) reported a patient with positive human T-lymphotrophic virus type I (HTLV-I) antibodies whose symptoms, similar to those of Shy-Drager syndrome, improved with corticosteroid therapy. They suggested that HTLV-I infection is related to Shy-Drager syndromelike neurological disorders. In fact, tremor has been reported in 27% and mild cerebellar ataxia in 5% of patients with usual HTLV-I-associated myelopathy (HAM), in addition to cardinal features of HAM; i.e., slowly progressive spastic paraparesis and mild sphincter and sensory disturbances 123.
๐ SIMILAR VOLUMES
Mitochondrial bioelectrocatalysis can be useful for sensing applications due to the unique metabolic pathways than can be selectively inhibited and uncoupled in mitochondria. This paper details the comparison of different inhibitors and nitro-containing explosive uncouplers in a mitochondria-catalyz
The inhibition patterns of rabbit sera (RS1 & RS2) from two different rabbits on the photosynthetic electron transport of isolated spinach thylakoids were studied. Fifty #1 of RSI were required for 100% inhibition of a H20 ~ MV/O2 reaction, while only 10 #1 of a I:10 dilution of RS2 were needed for
Mitochondrial dysfunction and degeneration are associated with many neurodegenerative disorders. A dysfunctional mitochondrial electron transport chain (ETC) impairs ATP production and accelerates the generation of free radicals. To evaluate mitochondrial function, reliable methods are needed. Conve